David Alan Caldwell - Aug 5, 2022 Form 3 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP - Strategy & Corp Dev
Signature
Jonathan Leiken, Attorney-in-fact for David Alan Caldwell
Stock symbol
DBD
Transactions as of
Aug 5, 2022
Transactions value $
$0
Form type
3
Date filed
8/19/2022, 08:49 AM
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DBD Common Shares 218K Aug 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option Aug 5, 2022 Common Shares 33.9K $4.08 Direct F2
holding DBD Non-Qualified Stock Option Aug 5, 2022 Common Shares 9.35K $11.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number includes restricted stock units.
F2 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.